Here would have been a good time to share the views that this study was flawed.....rather than bemoaning that these interventions are not available in the U.S.
*
February 17, 2011: Quoted by CNN in response to the PACE trial results:
The president and CEO of the Chronic Fatigue and Immune Dysfunction Syndrome Association of America, Kim McCleary, said the study focused on treatments that many in the United States have no access to.
“I think it would be challenging, at least in the U.S. system, to purchase the services that they’ve tested in this trial,” she said in a telephone interview.
The alphabet soup of acronyms that represent the interventions used in Britain is “just not something that our health care service offers, is reimbursable, or is really available here,” McCleary said.